RecruitingNot ApplicableNCT07177820
VGAIT for Chemotherapy-induced Peripheral Neuropathy
Video-Guided Acupuncture Imagery Treatment in Chemotherapy-induced Peripheral Neuropathy
Sponsor
Massachusetts General Hospital
Enrollment
20 participants
Start Date
Jan 6, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
Perform a feasibility study on imagined acupuncture treatment of Chemotherapy-induced peripheral neuropathy (CIPN)
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 80 Years
Inclusion Criteria4
- at least 18 years of age
- have histologically confirmed stage I-III breast cancer,
- have completed adjuvant taxane-based chemotherapy (alone or in combination), ,
- have an Eastern Cooperative Oncology Group performance status of 0 or 1, and reported grade 1 or greater CIPN symptoms for more than 2 weeks as defined by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), version 4.03.
Exclusion Criteria5
- concurrent chemotherapy (there were no limitations on time from the last paclitaxel administration),
- having metastatic or recurrent disease,
- history of preexisting peripheral neuropathy prior to chemotherapy,
- uncontrolled seizure disorder,
- unstable cardiac disease or myocardial infarction within 6 months prior to study entry, being pregnant or nursing, or having used acupuncture for CIPN within 6 months prior to study entry.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERVideo-Guided Acupuncture Imagery Treatment (VGAIT)
Participants watch a video of acupuncture being applied to the body while simultaneously imagining that it is being administered to them
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07177820
Related Trials
Physiologic Measure of VIPN
NCT047869771 location
Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer
NCT064901591 location
Self-applied taVNS for CIPN
NCT075960301 location
A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment
NCT073650071 location
A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy - Expansion Study
NCT056060682 locations